Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Leukemia-da Lymphoblastic ee daran (T-ALL)-03

Bukaanka: Huang XX

Jinsiga: Lab

Da'da: 42 sano jir

Jinsiyadda: Shiinees

Baadhista cudurka: Cudurka Kansarka Lymphoblastic Leukemia (T-ALL)

    Astaamaha Kiiska:

    - Baadhista: Cudurka 'pneum T-cell lymphoblastic leukemia' ee daran

    - Bilawga iyo Calaamadaha: Abriil 2020, oo lagu soo bandhigay wareer, daal, iyo dhibco dhiig ah oo maqaarka ah. Waxaa lagu ogaaday cudurka 'T-cell lymphoblastic leukemia' iyadoo la adeegsanayo baaritaanka MICM ee dhuuxa lafta.

    - Daaweynta Bilowga ah: Waxaa la gaaray cafis dhammaystiran (CR) ka dib daaweynta kiimoterabiga ee VDCLP, oo ay ku xigto 2 wareeg oo kiimoterabiga ah oo la xoojiyay.

    - Luulyo 19, 2020: Waxaa la siiyay tallaal unugyada asliga ah ee dhiigga oo allogeneic ah oo laga helay deeq-bixiye dumar ah (HLA 5/10 A deeq-bixiye A). Nidaamka qaboojinta waxaa ka mid ahaa shucaaca jirka oo dhan (TBI), cyclophosphamide (CY), iyo etoposide (VP-16). Unugyada asliga ah ee ku wareegsan ayaa la geliyay Luulyo 24, iyadoo soo kabashada granulocyte-ka ay ka soo kabato +10 iyo qorista platelet-ka maalinta +13. Dabagal joogto ah oo bukaan-socod ah ka dib.

    - Febraayo 25, 2021: Dib u soo noqoshada dhuuxa lafta ayaa la ogaaday intii lagu jiray dabagalka.

    - Daawaynta: Bilaabay daawaynta thalidomide ee afka laga qaato.

    - Maarso 8: Isbitaalkayaga ayaa la dhigay.

    - Qaab-dhismeedka Dhuuxa Lafaha: 61.5% qaraxyo.

    - Kala soocidda Dhiigga ee Dusha sare: 15% qaraxyo.

    - Tijaabinta Difaaca Jirka: 35.25% unugyo muujinaya CD99, CD5, CD3dim, CD8dim, CD7, cCD3, CD2dim, HLA-ABC, cbcl-2, CD81, CD38, oo muujinaya unugyada T ee aan qaan gaarin ee halista ah.

    - Falanqaynta Kroomosmka: 46, XX [9].

    - Hiddo-sidayaasha Isku-dhafka Leukemia: Hiddo-sidayaasha isku-dhafka SIL-TAL1 ee togan; cabbirka tirada: SIL-TA.

    - Isbeddelka Burada Dhiigga: Taban.

    - Falanqaynta Chimerism (ka dib HSCT): Unugyada ka soo jeeda deeq-bixiyayaashu waxay ahaayeen 45.78%.

    - Maarso 11: Ururinta unugyada dhiigga ee isku-dhafan ee iswada si loogu sameeyo unugyada CD7-CART.

    - Daawaynta: VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x 4 maalmood, Dex 9mg q12h x 9 maalmood) oo lagu daray thalidomide si loo xakameeyo burooyinka.

    - Maarso 19: Kiimikada daaweynta FC (Hargabka 50mg x 3 maalmood, CTX 0.4gx 3 maalmood).

    - Maarso 24 (kahor gelinta): Qaab-dhismeedka dhuuxa lafta ayaa muujiyay heerka V hyperplasia, iyadoo 22% qaraxyo ay dhaceen.

    - Cytometry Socodka Dhuuxa Lafaha: 29.21% unugyo (unugyada nuclear-ka) oo muujiya CD3, CD5, CD7, CD99, oo qayb ahaan muujiya cCD3, taasoo muujinaysa unugyada T ee aan qaan-gaarin ee halista ah.

    - Hiddo-sidayaasha Isku-dhafka SIL-TAL1 ee tirada leh: 1.913%.

    25dho

    Daaweynta:
    - Maarso 26: Ku shubidda unugyada CD7-CART ee iswada (5*10^5/kg)
    - Waxyeellooyinka La Xiriira CAR-T: CRS heerka 1aad (qandho), ma laha sunta neerfaha
    - Abriil 12 (Maalinta 17): Dabagalka ayaa muujiyay qaab-dhismeedka dhuuxa lafta marka la cafinayo, ma jiraan unugyo aan qaan-gaarin oo lagu ogaaday cytometry socodka, iyo qiyaasta hidda-wadaha isku-dhafka SIL-TAL1 (STIL-SCL) 0

    26i6g

    sharraxaad2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write